OSU’s Center for Health Systems Innovation targets atrial fibrillation in new study
Tuesday, January 13, 2015
The Oklahoma State University Center for Health Systems Innovation (CHSI) will be
joining several OSU Rural Health Network primary care physicians in a ground-breaking
study to discover incidence and management of silent atrial fibrillation.
The OSU Institutional Review Board (IRB) approved this new study, CHSI’s second rural
health project, on Dec. 17, 2014.
A growing problem in health care is the clinical and financial impact of asymptomatic
atrial fibrillation because it is most regularly found after stroke. Research has
shown that early detection and treatment of atrial fibrillation with oral anticoagulants
reduces strokes by 64 percent.
This semester, CHSI will launch a project looking into the rural incidence of silent
atrial fibrillation by utilizing a new handheld electrocardiogram (ECG) device, The
AliveCor® Heart Monitor, a mobile, clinical-quality ECG recorder which snaps onto
an iPod, iPhone or other smart phone models. While holding the device, a patient can
learn in 30 seconds whether he or she is experiencing atrial fibrillation. This FDA-approved
device is user-friendly, fast to produce results, and an affordable resource for rural
clinics.
Rural populations are at significantly higher risk of atrial fibrillation and stroke
due to their increased cardiovascular risk factors. Moreover, treating rural patients
may have additional challenges such as often having fewer resources available in their
communities.
In addition to exploring the incidence of undetected atrial fibrillation, the investigator’s
goals are also to better understand how obstacles in rural communities influence the
treatment of atrial fibrillation and how those can be overcome to better serve all
populations.
